Novartis Investigative Site

Nové Zámky, Slovakia 940 01

0 studies enrolling now · 2 studies all time

What they study most

Heart Failure With Reduced Ejection Fraction, Systolic Hypertension

Studies at this site

• An 8-week Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg in Patients With Mild-to-moderate Systolic Hypertension — Completed
• Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients — Completed